Zevesin

Medicinal product

(Invented) name

Zevesin

Active substance (s)

Solifenacino sukcinatas

Strength

5 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

G04BD08, Solifenacin

Marketing authorisation holder

UAB Tamro, Lietuva

Date of authorisation

2026-04-03

Date of renewal

Documents

3288_Zevesin 5mg_pl_deng_tab_PZ_2026-04-03.docx

3288_Zevesin 5mg_pl_deng_tab_PL_2026-04-03.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Solifenacino sukcinatas	5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
120415	106519	1106519	lizdinė plokštelė	N30		Receptinis	LT/L/26/3288/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2026-04-03	Registruotas